{"transactions":[{"id":698600,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":27114,"kind":"person","name":"Kaul Inderjit","position":1,"cik":"0002095703","reported_name":"Kaul Inderjit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-03T22:05:15.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":12147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shall vest on November 14, 2026; an additional 45% of the Consultant Option shall vest on the tenth day following the date of the Company's public announcement that it has achieved, on a statistically significant basis, the primary endpoint of its Phase 3 confirmatory trial of roluperidone in schizophrenia at the 12-week timepoint; and the remaining 30% of the Consultant Option shall vest on the tenth day following the date of the Company's public announcement of safety data from the 40-week relapse assessment phase; provided, however, in each case, that the Reporting Person is providing services pursuant to that certain consulting agreement dated November 14, 2025 on each such vesting date."}],"balance_after":12147,"derivative":{"exercise_price":3.97,"expiration_date":"2036-08-02","underlying":"Common Stock","underlying_shares":12147},"source":{"system":"sec-edgar","filing":"0002095703-26-000006","document":"form4-08032026_100811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000209570326000006/form4-08032026_100811.xml","form_type":"4"}},{"id":747773,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-05T22:00:17.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":680000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on June 3, 2027 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":680000,"derivative":{"exercise_price":4.68,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":680000},"source":{"system":"sec-edgar","filing":"0001405279-26-000002","document":"form4-06052026_060613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000140527926000002/form4-06052026_060613.xml","form_type":"4"}},{"id":747480,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-05T22:00:15.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1690700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on June 3, 2027 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":1690700,"derivative":{"exercise_price":4.68,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":1690700},"source":{"system":"sec-edgar","filing":"0001610384-26-000002","document":"form4-06052026_060611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000161038426000002/form4-06052026_060611.xml","form_type":"4"}},{"id":747897,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40916,"kind":"person","name":"Laghrissi-Thode Fouzia","position":1,"cik":"0001642015","reported_name":"Laghrissi-Thode Fouzia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T22:00:13.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.68,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001642015-26-000002","document":"form4-06052026_060609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642015/000164201526000002/form4-06052026_060609.xml","form_type":"4"}},{"id":747895,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40915,"kind":"person","name":"Kupfer David","position":1,"cik":"0001642053","reported_name":"Kupfer David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T22:00:11.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.68,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001642053-26-000002","document":"form4-06052026_060607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642053/000164205326000002/form4-06052026_060607.xml","form_type":"4"}},{"id":747479,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":27114,"kind":"person","name":"Kaul Inderjit","position":1,"cik":"0002095703","reported_name":"Kaul Inderjit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T22:00:09.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.68,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0002095703-26-000004","document":"form4-06052026_060605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000209570326000004/form4-06052026_060605.xml","form_type":"4"}},{"id":748627,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":41088,"kind":"person","name":"VAN HEEK G JAN","position":1,"cik":"0001021040","reported_name":"VAN HEEK G JAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T22:00:07.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.68,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001021040-26-000002","document":"form4-06052026_060603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021040/000102104026000002/form4-06052026_060603.xml","form_type":"4"}},{"id":747681,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T22:00:05.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.68,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001226286-26-000002","document":"form4-06052026_060601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226286/000122628626000002/form4-06052026_060601.xml","form_type":"4"}},{"id":802531,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":51602,"kind":"person","name":"O'Connor James Joseph","position":1,"cik":"0002129698","reported_name":"O'Connor James Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer and GC"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-04-22T20:55:18.000Z","date":"2026-04-21","kind":"grant","planned":false,"acquired":true,"shares":350800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on April 21, 2027 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":350800,"derivative":{"exercise_price":6.97,"expiration_date":"2036-04-20","underlying":"Common Stock","underlying_shares":350800},"source":{"system":"sec-edgar","filing":"0002129698-26-000004","document":"form4-04222026_080414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000212969826000004/form4-04222026_080414.xml","form_type":"4"}},{"id":822529,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":27114,"kind":"person","name":"Kaul Inderjit","position":1,"cik":"0002095703","reported_name":"Kaul Inderjit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-01T20:15:08.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":12169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shall vest on November 14, 2026; an additional 45% of the option shall vest on the tenth day following the date of the Issuer's public announcement that it has achieved, on a statistically significant basis, the primary endpoint of its Phase 3 confirmatory trial of roluperidone in schizophrenia at the 12-week timepoint; and the remaining 30% of the option shall vest on the tenth day following the date of the Issuer's public announcement of safety data from the 40-week relapse assessment phase; provided, however, in each case, that the Reporting Person is providing services pursuant to that certain consulting agreement dated November 14, 2025 on each such vesting date."}],"balance_after":12169,"derivative":{"exercise_price":6.03,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":12169},"source":{"system":"sec-edgar","filing":"0002095703-26-000002","document":"form4-04012026_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000209570326000002/form4-04012026_040401.xml","form_type":"4"}},{"id":959592,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40915,"kind":"person","name":"Kupfer David","position":1,"cik":"0001642053","reported_name":"Kupfer David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-23T21:15:22.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 22, 2025 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.98,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001642053-25-000004","document":"form4-12232025_041211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642053/000164205325000004/form4-12232025_041211.xml","form_type":"4"}},{"id":959356,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":27114,"kind":"person","name":"Kaul Inderjit","position":1,"cik":"0002095703","reported_name":"Kaul Inderjit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-23T21:15:21.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":364504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shall vest on November 14, 2026; an additional 45% of the option shall vest on the tenth day following the date of the Issuer's public announcement that it has achieved, on a statistically significant basis, the primary endpoint of its Phase 3 confirmatory trial of roluperidone in schizophrenia at the 12-week timepoint; and the remaining 30% of the option shall vest on the tenth day following the date of the Issuer's public announcement of safety data from the 40-week relapse assessment phase; provided, however, in each case, that the Reporting Person is providing services pursuant to that certain consulting agreement dated November 14, 2025 on each such vesting date."}],"balance_after":364504,"derivative":{"exercise_price":3.98,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":364504},"source":{"system":"sec-edgar","filing":"0002095703-25-000007","document":"form4-12232025_041215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000209570325000007/form4-12232025_041215.xml","form_type":"4"}},{"id":959456,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-23T21:15:20.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 22, 2025 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.98,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001226286-25-000003","document":"form4-12232025_041209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226286/000122628625000003/form4-12232025_041209.xml","form_type":"4"}},{"id":960130,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":41088,"kind":"person","name":"VAN HEEK G JAN","position":1,"cik":"0001021040","reported_name":"VAN HEEK G JAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-23T21:15:17.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 22, 2025 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.98,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001021040-25-000004","document":"form4-12232025_041213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021040/000102104025000004/form4-12232025_041213.xml","form_type":"4"}},{"id":959594,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40916,"kind":"person","name":"Laghrissi-Thode Fouzia","position":1,"cik":"0001642015","reported_name":"Laghrissi-Thode Fouzia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-23T21:15:17.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 22, 2025 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.98,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001642015-25-000004","document":"form4-12232025_041207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642015/000164201525000004/form4-12232025_041207.xml","form_type":"4"}},{"id":959499,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-23T21:15:15.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":500000,"derivative":{"exercise_price":3.98,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001405279-25-000004","document":"form4-12232025_041205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000140527925000004/form4-12232025_041205.xml","form_type":"4"}},{"id":959355,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-23T21:15:11.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":1500000,"derivative":{"exercise_price":3.98,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001610382-25-000004","document":"form4-12232025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000161038225000004/form4-12232025_041203.xml","form_type":"4"}},{"id":959354,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-23T21:15:09.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":2250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":2250000,"derivative":{"exercise_price":3.98,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":2250000},"source":{"system":"sec-edgar","filing":"0001610384-25-000005","document":"form4-12232025_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000161038425000005/form4-12232025_041201.xml","form_type":"4"}},{"id":995183,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":27114,"kind":"person","name":"Kaul Inderjit","position":1,"cik":"0002095703","reported_name":"Kaul Inderjit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-18T21:49:27.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in equal quarterly installments over three years with the first installment vesting on February 14, 2026, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":9500,"derivative":{"exercise_price":4.11,"expiration_date":"2035-11-13","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0002095703-25-000005","document":"form4-11182025_091123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000209570325000005/form4-11182025_091123.xml","form_type":"4"}},{"id":1340944,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":41088,"kind":"person","name":"VAN HEEK G JAN","position":1,"cik":"0001021040","reported_name":"VAN HEEK G JAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T22:45:18.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 5, 2024 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":2.12,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-24-028544","document":"form4-12062024_051214.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021040/000141588924028544/form4-12062024_051214.xml","form_type":"4"}},{"id":1340433,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40916,"kind":"person","name":"Laghrissi-Thode Fouzia","position":1,"cik":"0001642015","reported_name":"Laghrissi-Thode Fouzia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T22:45:16.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 5, 2024 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":2.12,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-24-028543","document":"form4-12062024_051212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642015/000141588924028543/form4-12062024_051212.xml","form_type":"4"}},{"id":1340432,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40915,"kind":"person","name":"Kupfer David","position":1,"cik":"0001642053","reported_name":"Kupfer David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T22:45:13.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 5, 2024 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":2.12,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-24-028542","document":"form4-12062024_051210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642053/000141588924028542/form4-12062024_051210.xml","form_type":"4"}},{"id":1340242,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T22:45:11.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following December 5, 2024 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":2.12,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-24-028541","document":"form4-12062024_051208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226286/000141588924028541/form4-12062024_051208.xml","form_type":"4"}},{"id":1340292,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-06T22:45:09.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 5, 2025 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":47500,"derivative":{"exercise_price":2.12,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001415889-24-028540","document":"form4-12062024_051206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000141588924028540/form4-12062024_051206.xml","form_type":"4"}},{"id":1340129,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-06T22:45:07.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 5, 2025 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":95000,"derivative":{"exercise_price":2.12,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001415889-24-028539","document":"form4-12062024_051203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000141588924028539/form4-12062024_051203.xml","form_type":"4"}},{"id":1340128,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-06T22:45:05.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 5, 2025 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":105000,"derivative":{"exercise_price":2.12,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001415889-24-028538","document":"form4-12062024_051201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000141588924028538/form4-12062024_051201.xml","form_type":"4"}},{"id":1764209,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-10-05T20:34:09.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":100450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on October 4, 2024 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":100450,"derivative":{"exercise_price":6.41,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":100450},"source":{"system":"sec-edgar","filing":"0001209191-23-052206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123052206/doc4.xml","form_type":"4"}},{"id":1764208,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-10-05T20:33:27.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":87050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on October 4, 2024 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":87050,"derivative":{"exercise_price":6.41,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":87050},"source":{"system":"sec-edgar","filing":"0001209191-23-052205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123052205/doc4.xml","form_type":"4"}},{"id":1764311,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-10-05T20:32:32.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":42850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on October 4, 2024 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":42850,"derivative":{"exercise_price":6.41,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":42850},"source":{"system":"sec-edgar","filing":"0001209191-23-052204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919123052204/doc4.xml","form_type":"4"}},{"id":1771429,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-29T13:00:02.000Z","date":"2023-09-27","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following September 27, 2023 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":7.3,"expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-050828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226286/000120919123050828/doc4.xml","form_type":"4"}},{"id":1771713,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":41088,"kind":"person","name":"VAN HEEK G JAN","position":1,"cik":"0001021040","reported_name":"VAN HEEK G JAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-29T12:59:29.000Z","date":"2023-09-27","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following September 27, 2023 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":7.3,"expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-050827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021040/000120919123050827/doc4.xml","form_type":"4"}},{"id":1771430,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29474,"kind":"person","name":"HILLEMAN JERYL L","position":1,"cik":"0001216628","reported_name":"HILLEMAN JERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-29T12:58:53.000Z","date":"2023-09-27","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following September 27, 2023 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":7.3,"expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-050826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216628/000120919123050826/doc4.xml","form_type":"4"}},{"id":1771507,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40915,"kind":"person","name":"Kupfer David","position":1,"cik":"0001642053","reported_name":"Kupfer David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-29T12:58:14.000Z","date":"2023-09-27","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following September 27, 2023 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":7.3,"expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-050825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642053/000120919123050825/doc4.xml","form_type":"4"}},{"id":1771508,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40916,"kind":"person","name":"Laghrissi-Thode Fouzia","position":1,"cik":"0001642015","reported_name":"Laghrissi-Thode Fouzia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-29T12:57:42.000Z","date":"2023-09-27","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 12,500 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following September 27, 2023 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":7.3,"expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-050824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642015/000120919123050824/doc4.xml","form_type":"4"}},{"id":1907884,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-02T22:15:06.000Z","date":"2023-05-02","kind":"sale","planned":false,"acquired":false,"shares":3641,"price":3.76,"value":13690.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.90 inclusive."}],"balance_after":68994,"source":{"system":"sec-edgar","filing":"0001209191-23-026683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123026683/doc4.xml","form_type":"4"}},{"id":1907883,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-02T22:15:06.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":23753,"price":3.85,"value":91449.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $4.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4)."}],"balance_after":72635,"source":{"system":"sec-edgar","filing":"0001209191-23-026683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123026683/doc4.xml","form_type":"4"}},{"id":1907882,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-02T22:15:06.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":88077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon the vesting of performance-based restricted stock units (\"PRSUs\"), representing 50% of the shares underlying the PRSUs. On April 28, 2023, the Compensation Committee of the Board of Directors of the Issuer certified the achievement of a performance condition, which occurs upon FDA acceptance of a new drug application for roluperidone."}],"balance_after":96388,"source":{"system":"sec-edgar","filing":"0001209191-23-026683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123026683/doc4.xml","form_type":"4"}},{"id":1907881,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-05-02T22:14:21.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":22082,"price":3.85,"value":85015.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $4.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":51324,"source":{"system":"sec-edgar","filing":"0001209191-23-026681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123026681/doc4.xml","form_type":"4"}},{"id":1907880,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-05-02T22:14:21.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":46987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon the vesting of performance-based restricted stock units (\"PRSUs\"), representing 50% of the shares underlying the PRSUs. On April 28, 2023, the Compensation Committee of the Board of Directors of the Issuer certified the achievement of a performance condition, which occurs upon FDA acceptance of a new drug application for roluperidone."}],"balance_after":73406,"source":{"system":"sec-edgar","filing":"0001209191-23-026681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123026681/doc4.xml","form_type":"4"}},{"id":1908129,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Secretary"}}],"security":"Common Stock","published_at":"2023-05-02T22:13:49.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":3580,"price":4.48,"value":16038.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.31 to $4.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":17518,"source":{"system":"sec-edgar","filing":"0001209191-23-026678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919123026678/doc4.xml","form_type":"4"}},{"id":1908128,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Secretary"}}],"security":"Common Stock","published_at":"2023-05-02T22:13:49.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":19843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon the vesting of performance-based restricted stock units (\"PRSUs\"), representing 50% of the shares underlying the PRSUs. On April 28, 2023, the Compensation Committee of the Board of Directors of the Issuer certified the achievement of a performance condition, which occurs upon FDA acceptance of a new drug application for roluperidone."}],"balance_after":21098,"source":{"system":"sec-edgar","filing":"0001209191-23-026678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919123026678/doc4.xml","form_type":"4"}},{"id":2086134,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-14T21:50:22.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 13, 2023 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":45000,"derivative":{"exercise_price":3.11,"expiration_date":"2032-12-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-22-061239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919122061239/doc4.xml","form_type":"4"}},{"id":2086133,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-14T21:48:49.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 13, 2023 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":38000,"derivative":{"exercise_price":3.11,"expiration_date":"2032-12-12","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001209191-22-061238","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919122061238/doc4.xml","form_type":"4"}},{"id":2086366,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-14T21:47:53.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 13, 2023 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":26000,"derivative":{"exercise_price":3.11,"expiration_date":"2032-12-12","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-22-061237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919122061237/doc4.xml","form_type":"4"}},{"id":2220050,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29474,"kind":"person","name":"HILLEMAN JERYL L","position":1,"cik":"0001216628","reported_name":"HILLEMAN JERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-28T23:36:18.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Issuer's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 2,500 shares of common stock per year."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 10, 2022 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."}],"balance_after":2500,"derivative":{"exercise_price":3.32,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-039689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216628/000120919122039689/doc4.xml","form_type":"4"}},{"id":2220055,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-28T23:35:30.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Issuer's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 2,500 shares of common stock per year."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 10, 2022 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."}],"balance_after":2500,"derivative":{"exercise_price":3.32,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-039688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000120919122039688/doc4.xml","form_type":"4"}},{"id":2220049,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-28T23:34:39.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Issuer's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 2,500 shares of common stock per year."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 10, 2022 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."}],"balance_after":2500,"derivative":{"exercise_price":3.32,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-039686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226286/000120919122039686/doc4.xml","form_type":"4"}},{"id":2220468,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":41088,"kind":"person","name":"VAN HEEK G JAN","position":1,"cik":"0001021040","reported_name":"VAN HEEK G JAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-28T23:33:55.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Issuer's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 2,500 shares of common stock per year."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 10, 2022 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."}],"balance_after":2500,"derivative":{"exercise_price":3.32,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-039685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021040/000120919122039685/doc4.xml","form_type":"4"}},{"id":2220134,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40915,"kind":"person","name":"Kupfer David","position":1,"cik":"0001642053","reported_name":"Kupfer David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-28T23:33:16.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Issuer's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 2,500 shares of common stock per year."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 10, 2022 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been\nadjusted to give effect to the Reverse Stock Split."}],"balance_after":2500,"derivative":{"exercise_price":3.32,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-039684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642053/000120919122039684/doc4.xml","form_type":"4"}},{"id":2220135,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40916,"kind":"person","name":"Laghrissi-Thode Fouzia","position":1,"cik":"0001642015","reported_name":"Laghrissi-Thode Fouzia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-28T23:32:36.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Issuer's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 2,500 shares of common stock per year."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 10, 2022 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 17, 2022, the Issuer completed a 1-for-8 reverse stock split of the Issuer's common stock (\"Reverse Stock Split\"). This amount has been adjusted to give effect to the Reverse Stock Split."}],"balance_after":2500,"derivative":{"exercise_price":3.32,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-039683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642015/000120919122039683/doc4.xml","form_type":"4"}},{"id":2385126,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-18T21:36:38.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":180000,"derivative":{"exercise_price":0.791,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-22-011313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919122011313/doc4.xml","form_type":"4"}},{"id":2384744,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-18T21:34:42.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":200000,"derivative":{"exercise_price":0.791,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-22-011304","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919122011304/doc4.xml","form_type":"4"}},{"id":2384743,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-18T21:33:11.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":505000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":505000,"derivative":{"exercise_price":0.791,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":505000},"source":{"system":"sec-edgar","filing":"0001209191-22-011299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919122011299/doc4.xml","form_type":"4"}},{"id":2485903,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40915,"kind":"person","name":"Kupfer David","position":1,"cik":"0001642053","reported_name":"Kupfer David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-03T22:37:31.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":55635,"price":0.88,"value":48958.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.85 to $0.9235 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":163553,"source":{"system":"sec-edgar","filing":"0001209191-21-067938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642053/000120919121067938/doc4.xml","form_type":"4"}},{"id":2665855,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T20:36:09.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-040932","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226286/000120919121040932/doc4.xml","form_type":"4"}},{"id":2667952,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T21:49:54.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 40,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-040687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000120919121040687/doc4.xml","form_type":"4"}},{"id":2669086,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":41088,"kind":"person","name":"VAN HEEK G JAN","position":1,"cik":"0001021040","reported_name":"VAN HEEK G JAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T21:47:34.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-040683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021040/000120919121040683/doc4.xml","form_type":"4"}},{"id":2667930,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29474,"kind":"person","name":"HILLEMAN JERYL L","position":1,"cik":"0001216628","reported_name":"HILLEMAN JERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T21:47:03.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-040680","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216628/000120919121040680/doc4.xml","form_type":"4"}},{"id":2668290,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40916,"kind":"person","name":"Laghrissi-Thode Fouzia","position":1,"cik":"0001642015","reported_name":"Laghrissi-Thode Fouzia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T21:42:00.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-040675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642015/000120919121040675/doc4.xml","form_type":"4"}},{"id":2668289,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40915,"kind":"person","name":"Kupfer David","position":1,"cik":"0001642053","reported_name":"Kupfer David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T21:40:36.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.9,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-040673","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642053/000120919121040673/doc4.xml","form_type":"4"}},{"id":2941868,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":21158,"kind":"person","name":"Reilly Joseph H.","position":1,"cik":"0001610499","reported_name":"Reilly Joseph H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T01:37:52.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001209191-20-063926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063926/doc4.xml","form_type":"4"}},{"id":2941867,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":21158,"kind":"person","name":"Reilly Joseph H.","position":1,"cik":"0001610499","reported_name":"Reilly Joseph H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-17T01:37:52.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":3228,"price":2.64,"value":8521.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":31747,"source":{"system":"sec-edgar","filing":"0001209191-20-063926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063926/doc4.xml","form_type":"4"}},{"id":2941866,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":21158,"kind":"person","name":"Reilly Joseph H.","position":1,"cik":"0001610499","reported_name":"Reilly Joseph H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-17T01:37:52.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":8750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":34975,"source":{"system":"sec-edgar","filing":"0001209191-20-063926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063926/doc4.xml","form_type":"4"}},{"id":2941871,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T01:31:00.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-20-063924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063924/doc4.xml","form_type":"4"}},{"id":2941870,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2020-12-17T01:31:00.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":6190,"price":2.64,"value":16341.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":211354,"source":{"system":"sec-edgar","filing":"0001209191-20-063924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063924/doc4.xml","form_type":"4"}},{"id":2941869,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2020-12-17T01:31:00.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":217544,"source":{"system":"sec-edgar","filing":"0001209191-20-063924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063924/doc4.xml","form_type":"4"}},{"id":2941865,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T01:29:53.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-20-063923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063923/doc4.xml","form_type":"4"}},{"id":2941864,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-17T01:29:53.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":1300,"price":2.64,"value":3432.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":66490,"source":{"system":"sec-edgar","filing":"0001209191-20-063923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063923/doc4.xml","form_type":"4"}},{"id":2941863,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-17T01:29:53.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":67790,"source":{"system":"sec-edgar","filing":"0001209191-20-063923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063923/doc4.xml","form_type":"4"}},{"id":2942300,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T01:29:02.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-063922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919120063922/doc4.xml","form_type":"4"}},{"id":2942299,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-12-17T01:29:02.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":1845,"price":2.64,"value":4870.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":10039,"source":{"system":"sec-edgar","filing":"0001209191-20-063922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919120063922/doc4.xml","form_type":"4"}},{"id":2942298,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-12-17T01:29:02.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":11884,"source":{"system":"sec-edgar","filing":"0001209191-20-063922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919120063922/doc4.xml","form_type":"4"}},{"id":3006805,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-14T21:22:17.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022."}],"balance_after":140000,"derivative":{"exercise_price":3.5,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001209191-20-054806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120054806/doc4.xml","form_type":"4"}},{"id":3006806,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-14T21:21:16.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022."}],"balance_after":200000,"derivative":{"exercise_price":3.5,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-054805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120054805/doc4.xml","form_type":"4"}},{"id":3006804,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":21158,"kind":"person","name":"Reilly Joseph H.","position":1,"cik":"0001610499","reported_name":"Reilly Joseph H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-14T21:19:22.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022."}],"balance_after":85000,"derivative":{"exercise_price":3.5,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-20-054803","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120054803/doc4.xml","form_type":"4"}},{"id":3007094,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-14T21:18:19.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022."}],"balance_after":85000,"derivative":{"exercise_price":3.5,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-20-054801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919120054801/doc4.xml","form_type":"4"}},{"id":3006807,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":145965,"kind":"person","name":"Saoud Jay","position":1,"cik":"0001716202","reported_name":"Saoud Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Head of R&D"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-14T21:16:48.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022."}],"balance_after":100000,"derivative":{"exercise_price":3.5,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-054800","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120054800/doc4.xml","form_type":"4"}},{"id":3007302,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-14T17:23:30.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022."}],"balance_after":85000,"derivative":{"exercise_price":3.5,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-20-054807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000120919120054807/doc4.xml","form_type":"4"}},{"id":3007211,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":145974,"kind":"person","name":"Davidson Michael","position":1,"cik":"0001691467","reported_name":"Davidson Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-14T17:20:20.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022."}],"balance_after":85000,"derivative":{"exercise_price":3.5,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-20-054804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691467/000120919120054804/doc4.xml","form_type":"4"}},{"id":3033562,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":41088,"kind":"person","name":"VAN HEEK G JAN","position":1,"cik":"0001021040","reported_name":"VAN HEEK G JAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-11T21:13:50.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":7000,"price":2.97,"value":20790.0,"ownership":{"direct":true},"balance_after":20333,"source":{"system":"sec-edgar","filing":"0001209191-20-050176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021040/000120919120050176/doc4.xml","form_type":"4"}},{"id":3055487,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":145965,"kind":"person","name":"Saoud Jay","position":1,"cik":"0001716202","reported_name":"Saoud Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Head of R&D"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T20:31:55.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":236202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":236202,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":236202},"source":{"system":"sec-edgar","filing":"0001209191-20-046954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120046954/doc4.xml","form_type":"4"}},{"id":3055486,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":147153,"kind":"person","name":"Russell Richard E.","position":1,"cik":"0001724897","reported_name":"Russell Richard E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T20:30:52.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":185025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":185025,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":185025},"source":{"system":"sec-edgar","filing":"0001209191-20-046953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120046953/doc4.xml","form_type":"4"}},{"id":3055485,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":21158,"kind":"person","name":"Reilly Joseph H.","position":1,"cik":"0001610499","reported_name":"Reilly Joseph H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T20:30:00.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":153531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":153531,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":153531},"source":{"system":"sec-edgar","filing":"0001209191-20-046952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120046952/doc4.xml","form_type":"4"}},{"id":3055484,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T20:29:03.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":275568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":275568,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":275568},"source":{"system":"sec-edgar","filing":"0001209191-20-046950","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120046950/doc4.xml","form_type":"4"}},{"id":3055481,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T20:28:02.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":354302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":354302,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":354302},"source":{"system":"sec-edgar","filing":"0001209191-20-046949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120046949/doc4.xml","form_type":"4"}},{"id":3055719,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T20:25:55.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":137784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":137784,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":137784},"source":{"system":"sec-edgar","filing":"0001209191-20-046947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919120046947/doc4.xml","form_type":"4"}},{"id":3056053,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T16:32:52.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":153531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":153531,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":153531},"source":{"system":"sec-edgar","filing":"0001209191-20-046957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000120919120046957/doc4.xml","form_type":"4"}},{"id":3055975,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":145974,"kind":"person","name":"Davidson Michael","position":1,"cik":"0001691467","reported_name":"Davidson Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T16:27:03.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":137784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":137784,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":137784},"source":{"system":"sec-edgar","filing":"0001209191-20-046948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691467/000120919120046948/doc4.xml","form_type":"4"}},{"id":3112328,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":41088,"kind":"person","name":"VAN HEEK G JAN","position":1,"cik":"0001021040","reported_name":"VAN HEEK G JAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T21:02:18.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.4,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-036342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021040/000120919120036342/doc4.xml","form_type":"4"}},{"id":3111889,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40916,"kind":"person","name":"Laghrissi-Thode Fouzia","position":1,"cik":"0001642015","reported_name":"Laghrissi-Thode Fouzia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T21:01:22.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.4,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-036339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642015/000120919120036339/doc4.xml","form_type":"4"}},{"id":3111887,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40915,"kind":"person","name":"Kupfer David","position":1,"cik":"0001642053","reported_name":"Kupfer David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T21:00:26.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.4,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-036337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642053/000120919120036337/doc4.xml","form_type":"4"}},{"id":3111538,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29474,"kind":"person","name":"HILLEMAN JERYL L","position":1,"cik":"0001216628","reported_name":"HILLEMAN JERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T20:59:37.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.4,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-036336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216628/000120919120036336/doc4.xml","form_type":"4"}},{"id":3111531,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T20:58:32.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.4,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-036335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226286/000120919120036335/doc4.xml","form_type":"4"}},{"id":3111554,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T20:57:47.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. An additional option grant to purchase 20,000 shares of common stock  was granted to the Reporting Person at the discretion of the Company's board of directors for such Reporting Person's service as lead independent director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.4,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-036331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194459/000120919120036331/doc4.xml","form_type":"4"}},{"id":3133477,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40883,"kind":"person","name":"Ahlholm Frederick W","position":1,"cik":"0001405279","reported_name":"Ahlholm Frederick W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-05-27T20:43:53.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":8339,"price":15,"value":125085.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2019."}],"balance_after":6884,"source":{"system":"sec-edgar","filing":"0001209191-20-032322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405279/000120919120032322/doc4.xml","form_type":"4"}},{"id":3321430,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":145965,"kind":"person","name":"Saoud Jay","position":1,"cik":"0001716202","reported_name":"Saoud Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Head of R&D"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-03T21:52:49.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":63798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":63798,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":63798},"source":{"system":"sec-edgar","filing":"0001209191-20-001125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120001125/doc4.xml","form_type":"4"}},{"id":3321429,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":147153,"kind":"person","name":"Russell Richard E.","position":1,"cik":"0001724897","reported_name":"Russell Richard E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-03T21:51:53.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":49975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":49975,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":49975},"source":{"system":"sec-edgar","filing":"0001209191-20-001119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120001119/doc4.xml","form_type":"4"}},{"id":3321428,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":21158,"kind":"person","name":"Reilly Joseph H.","position":1,"cik":"0001610499","reported_name":"Reilly Joseph H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-03T21:50:52.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":41469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":41469,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":41469},"source":{"system":"sec-edgar","filing":"0001209191-20-001116","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120001116/doc4.xml","form_type":"4"}},{"id":3321427,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":70878,"kind":"person","name":"Race Geoff","position":1,"cik":"0001610382","reported_name":"Race Geoff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-03T21:49:46.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":74432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":74432,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":74432},"source":{"system":"sec-edgar","filing":"0001209191-20-001114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120001114/doc4.xml","form_type":"4"}},{"id":3321426,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-03T21:48:34.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":95698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":95698,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":95698},"source":{"system":"sec-edgar","filing":"0001209191-20-001107","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120001107/doc4.xml","form_type":"4"}}],"next_cursor":"2020-01-03T21:48:34.000000Z,3321426"}